Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T C Chan

Showing results (241-250 of 407) with videos related to

Pageof 41
Sort By:
Investigational New Drugs|August 12, 2023
Preclinical evaluation of the VEGF/Ang2 bispecific nanobody BI 836880 in nasopharyngeal carcinoma modelsRachel C T Lam, Connie W C Hui, C H Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Plasma osteopontin, hypoxia, and response to radiotherapy in nasopharyngeal cancerEdwin P Hui, Fion L Sung, Brian K H Yu, et al.
World Journal of Gastroenterology|January 21, 2006
Correlation and prognostic significance of beta-galactoside alpha-2,6-sialyltransferase and serum monosialylated alpha-fetoprotein in hepatocellular carcinomaTerence C W Poon, Clarissa H S Chiu, Paul B S Lai, et al.
Cancer|July 9, 2004
Lung metastasis alone in nasopharyngeal carcinoma: a relatively favorable prognostic group. A study by the Hong Kong Nasopharyngeal Carcinoma Study GroupEdwin P Hui, Sing F Leung, Joseph S K Au, et al.
Investigational New Drugs|September 14, 2007
A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cellsBrigette Ma, Boon Cher Goh, Eng Huat Tan, et al.
Clinical Chemistry|April 24, 2003
Quantitative analysis of pleural fluid cell-free DNA as a tool for the classification of pleural effusionsMichael H M Chan, Kai Ming Chow, Anthony T C Chan, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 21, 2018
The Use of Post-ablation Stimulated Thyroglobulin in Predicting Clinical Outcomes in Differentiated Thyroid Carcinoma - What Cut-off Values Should We Use?K C W Wong, T Y Ng, K S Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Rapid clearance of plasma Epstein-Barr virus DNA after surgical treatment of nasopharyngeal carcinomaEdward W H To, K C Allen Chan, Sing-Fai Leung, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 6, 2019
Cost-effectiveness of Screening for Nasopharyngeal Carcinoma among Asian American Men in the United StatesJeremy P Harris, Anirudh Saraswathula, Brian Kaplun, et al.
The British Journal of Radiology|March 18, 2008
The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosisA D King, B B Ma, Y Y Yau, et al.
Pageof 41

Showing results (241-250 of 407) with videos related to

Sort By:
Pageof 41
Investigational New Drugs|August 12, 2023
Preclinical evaluation of the VEGF/Ang2 bispecific nanobody BI 836880 in nasopharyngeal carcinoma modelsRachel C T Lam, Connie W C Hui, C H Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Plasma osteopontin, hypoxia, and response to radiotherapy in nasopharyngeal cancerEdwin P Hui, Fion L Sung, Brian K H Yu, et al.
World Journal of Gastroenterology|January 21, 2006
Correlation and prognostic significance of beta-galactoside alpha-2,6-sialyltransferase and serum monosialylated alpha-fetoprotein in hepatocellular carcinomaTerence C W Poon, Clarissa H S Chiu, Paul B S Lai, et al.
Cancer|July 9, 2004
Lung metastasis alone in nasopharyngeal carcinoma: a relatively favorable prognostic group. A study by the Hong Kong Nasopharyngeal Carcinoma Study GroupEdwin P Hui, Sing F Leung, Joseph S K Au, et al.
Investigational New Drugs|September 14, 2007
A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cellsBrigette Ma, Boon Cher Goh, Eng Huat Tan, et al.
Clinical Chemistry|April 24, 2003
Quantitative analysis of pleural fluid cell-free DNA as a tool for the classification of pleural effusionsMichael H M Chan, Kai Ming Chow, Anthony T C Chan, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 21, 2018
The Use of Post-ablation Stimulated Thyroglobulin in Predicting Clinical Outcomes in Differentiated Thyroid Carcinoma - What Cut-off Values Should We Use?K C W Wong, T Y Ng, K S Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Rapid clearance of plasma Epstein-Barr virus DNA after surgical treatment of nasopharyngeal carcinomaEdward W H To, K C Allen Chan, Sing-Fai Leung, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|March 6, 2019
Cost-effectiveness of Screening for Nasopharyngeal Carcinoma among Asian American Men in the United StatesJeremy P Harris, Anirudh Saraswathula, Brian Kaplun, et al.
The British Journal of Radiology|March 18, 2008
The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosisA D King, B B Ma, Y Y Yau, et al.
Pageof 41